Health

US Biotechnology Company Moderna Receives FDA 'Fast Track' Designation For COVID-19 Vaccine

The US Food and Drug Administration (FDA) gave "fast track" designation to an American Biotechnology Company Moderna Therapeutics' experimental coronavirus vaccine mRNA-1273. On Tuesday, May 12, the California based biopharmaceutical firm announced that they got a nod from FDA to go ahead with mRNA...